Association of Histone Deacetylase Expression With Histology and Prognosis of Ovarian Cancer

Oncology Letters - Greece
doi 10.3892/ol.2018.7726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Cancers
Cancer ResearchOncology
2019English

Association of P16 Expression With Prognosis Varies Across Ovarian Carcinoma Histotypes: An Ovarian Tumor Tissue Analysis Consortium Study

Journal of Pathology: Clinical Research
Forensic MedicinePathology
2018English

Histone Deacetylase Inhibitors and Aspirin Interact Synergistically to Induce Cell Death in Ovarian Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2008English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer With Low Xist Expression

Clinical Cancer Research
Cancer ResearchOncology
2013English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors

Seminars in Cancer Biology
Cancer Research
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy